<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> frequently causes <z:hpo ids='HP_0000618'>blindness</z:hpo>, especially in patients with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (T2D) </plain></SENT>
<SENT sid="1" pm="."><plain>The implementation of systematic screening can improve the visual prognosis significantly, and recently decision models that allow individualised determination of control intervals on the basis of known risk factors have been introduced </plain></SENT>
<SENT sid="2" pm="."><plain>Current treatment of diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> with <z:chebi fb="46" ids="15035">retinal</z:chebi> photocoagulation has adverse effects with severe consequences for patients with T2D </plain></SENT>
<SENT sid="3" pm="."><plain>However, recently intravitreal angiostatic therapy has been introduced as an effective new modality for the treatment of diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> </plain></SENT>
</text></document>